Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin
NCT02404493 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2017-03-24
Summary
The purpose of this 3 week study is to test the effectiveness of an over-the-counter (OTC) skin balm in infants and toddlers with mild to moderate dry, itchy skin.
Conditions
Interventions
- DEVICE
-
EpiCeram Skin Barrier Emulsion
EpiCeram Skin Barrier Emulsion
- DRUG
-
1% Colloidal Oatmeal Balm
Experimental Product 1% Colloidal Oatmeal Balm
Sponsors & Collaborators
-
Johnson & Johnson Consumer Inc. (J&JCI)
lead INDUSTRY
Principal Investigators
-
Amisha Parikh-Das, PhD · Johnson & Johnson Consumer Inc. (J&JCI)
-
Ethlynn Schorr, MD · TKL Research, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 47 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- United States
Study Locations
More Related Trials
-
To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin
NCT02857062 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.
NCT04950374 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
NCT00828412 ·Status: COMPLETED ·Phase: PHASE4
-
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
NCT01577628 ·Status: TERMINATED ·Phase: NA
-
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children
NCT00886587 ·Status: COMPLETED ·Phase: NA
-
Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis
NCT06474728 ·Status: COMPLETED ·Phase: NA
-
Barrier Enhancement for Eczema Prevention
NCT04680520 ·Status: COMPLETED ·Phase: NA
-
Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study
NCT04936113 ·Status: TERMINATED ·Phase: PHASE2
-
A Tolerability Assessment Study of Three Wash Products in Infants
NCT02403999 ·Status: COMPLETED ·Phase: NA
-
EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic Eczema
NCT03376243 ·Status: COMPLETED ·Phase: NA
-
Atopic Dermatitis in Atopy Predisposed Infants
NCT02906475 ·Status: COMPLETED ·Phase: NA
-
Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood
NCT04398758 ·Status: UNKNOWN ·Phase: PHASE3
-
Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product
NCT02615561 ·Status: COMPLETED ·Phase: NA
-
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381 ·Status: UNKNOWN
-
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
NCT01375205 ·Status: COMPLETED ·Phase: NA
-
Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis
NCT06487000 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Randomized Controlled Trial of an Eczema Care Plan
NCT02251340 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
NCT03143504 ·Status: UNKNOWN
-
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343 ·Status: RECRUITING ·Phase: NA
-
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NCT00806221 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)
NCT01781663 ·Status: UNKNOWN ·Phase: PHASE4
-
Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis
NCT00931411 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
NCT02118766 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.
NCT05062213 ·Status: COMPLETED ·Phase: NA
-
A Community-based Assessment of Skin Care, Allergies, and Eczema
NCT03409367 ·Status: COMPLETED ·Phase: NA